Cambridge Healthtech Institute’s 6th Annual

Risk-Based Quality Management and Monitoring

Beyond COVID-19: Tools and Processes to Accelerate RBQM and Improve Monitoring

17-18 October 2023


We are pleased to announce production of Cambridge Healthtech Institute’s “Risk-Based Quality Management and Monitoring: Integrating Quality into Clinical Trials to Ensure Effective Monitoring” being held 17-18 October 2023 at the InterContinental Barcelona-Fira Center in Barcelona, Spain.


Where RBQM implementation had proceeded in a conservative, iterative manner pre-pandemic, the challenges presented during this unexpected crisis resulted in acceleration with respect to onsite and remote monitoring practices in clinical trials. With the backdrop of lessons from COVID-19, CHI’s 6th Annual Risk-Based Quality Management and Monitoring conference provides processes and tools for acceleration of RBQM implementation, regulatory requirements, QTL & KRI setup and monitoring, early risk and issue detection, and monitoring approaches. The gathering will be part of the Summit for Clinical Trials Operations Executives (SCOPE) Europe, a two-day event made up of shared plenary keynotes from biopharma thought leaders, 4 conference programs focused on specific issues and functions within the clin ops, innovation and research enterprise, informal and interactive breakout discussion groups, and networking. Please see the overall program map below for 2023. Topics to be discussed at the “Risk-Based Quality Management and Monitoring” conference program include:


  • Central monitoring implementation and best practices
  • Remote monitoring
  • Metrics, QTL, KRI setup and monitoring
  • Quality by design
  • Data quality and analytics
  • ICH Renovation of GCP

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for priority consideration is 17 March, 2023.


We are looking for actual implementation stories and lessons learned, not theoretical talks. Co-presentations featuring speakers from different departments involved in the project are encouraged.


Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators, and those from academic/hospital centers. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.


For more details on the conference, please contact:
Bridget Kotelly
Conference Producer
Cambridge Healthtech Institute (CHI)

For partnering and sponsorship information, please contact:

Companies A-I:
Ilana Quigley
Assistant Sales Director
Cambridge Healthtech Institute (CHI)

Companies J-Q
Jon Stroup
Sr. Manger, Business Development
Cambridge Healthtech Institute

Companies R-Z:
Patty Rose
Sales Director
Cambridge Healthtech Institute (CHI)

For media and association partnerships, please contact:
Rich Handy
Senior Director, Marketing
Cambridge Healthtech Institute (CHI)